Log in to save to my catalogue

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5814521

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

About this item

Full title

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

Publisher

Cham: Springer International Publishing

Journal title

Clinical pharmacokinetics, 2018-03, Vol.57 (3), p.267-286

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Micafungin is a selective inhibitor of the synthesis of fungal 1,3-β-
d
-glucan, an essential component of the fungal cell wall. It is available as a powder for infusion only and is registered for the treatment of invasive and esophageal candidiasis in addition to prophylaxis of
Candida
infections in both adults and children. Average ex...

Alternative Titles

Full title

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5814521

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5814521

Other Identifiers

ISSN

0312-5963

E-ISSN

1179-1926

DOI

10.1007/s40262-017-0578-5

How to access this item